An observational study in Osteoarthritis Metacarpophalangeal Joint and Rheumatoid Arthritis Metacarpophalangeal Joint, sponsored by Waldfriede Hospital. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by Waldfriede Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 131 studies in Osteoarthritis with a site in Germany — 12 open to participants now, 27 under way, 3 of them phase 3. Osteoarthritis · Germany.
Among the 131 studies in Osteoarthritis with a site in Germany, this one is the 16th largest by planned enrollment of the 31 observational ones that give a count, is one of 6 that started in 2024, is one of 31 observational ones, reaches primary completion later than 3 of the 26 other live ones, and was the 120th registered.
2,974 studies on the registry are indexed under Osteoarthritis; 437 are open to participants now.
Browse Osteoarthritis studies →12 of the 131 studies in Osteoarthritis with a site in Germany are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Germany, United States, Argentina and 10 more countries
Ages 18+
University Hospital, Basel, Switzerland · Sites in Germany, Austria, Croatia and 5 more countries
Ages 18–70
Charite University, Berlin, Germany · Sites in Germany
Ages 18–50
University Hospital, Basel, Switzerland · Sites in Germany, Croatia, Switzerland
Ages 18–65
Charite University, Berlin, Germany · Sites in Germany
Ages 18–85
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 286 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 71 (25%) stop at 75 or younger; 22 take children under 18; 30 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
131 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 24 · Phase 3 23 · Phase 4 12
First in 2000; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is close to the median of 100 across 601 observational studies indexed under Osteoarthritis.
Median enrollment 139 across the 98 interventional studies, 100 across the 31 observational. Of the 96 that completed or were terminated, 28 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
94 of 131 have an industry lead sponsor. The 10 most frequent:
Waldfriede Hospital is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Waldfriede Hospital has 3 studies filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
7 of the studies in Osteoarthritis with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07352540Phase 3University of Erlangen-Nürnberg Medical SchoolSingle vs Triple Hyaluronic Acid in Knee Osteoarthritis | 2026-12-15 |
| NCT02337244Zimmer, GmbHZimmer POLAR Persona - TKA (EMEA Study) | 2026-12 |
| NCT02351414MicroPort Orthopedics Inc.Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | 2027-06 |
| NCT02823834MicroPort Orthopedics Inc.PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components | 2027-06 |
| NCT02038140Zimmer BiometZimmer Trabecular Metal Total Ankle PMCF | 2027-09 |
Add all 7 to your calendar (.ics) → With an account.
Among the 131 studies in Osteoarthritis with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary working hypothesis of this study is whether KeriFlex® metacarpophalangeal joint prostheses provide an equivalent result to Swanson finger joint implants in patients with rheumatoid arthritis or post-traumatic osteoarthritis. Functional status will be measured by Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire no earlier than 1 year after surgery.
Individuals who have either suffered Metacarpophalangeal joint destruction due to rheumatiod arthritis inflammation, or individuals who have received joint implant due to post-traumatic osteoarthritis of the Metacarpophalangeal joint.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Metacarpophalangeal Joint Prostheses between 2014 and 2022 using Swanson or KeriFlex implant system at Hospital Waldfriede
Exclusion Criteria:
Patients with rheumatoid arthritis who received a metacarpophalangeal joint prostheses system after 01.01.2014
Procedure: Metacarpophalangeal joint prostheses
Patients with post-traumatic wrist osteoarthritis who received a metacarpophalangeal joint prostheses system after 01.01.2014
Procedure: Metacarpophalangeal joint prostheses
Observation after implantation of metacarpophalangeal joint prostheses using KeriFlex® or Swanson finger joint implants
Observation after implantation of metacarpophalangeal joint prostheses using KeriFlex® or Swanson finger joint implants
Disabilities of the Arm, Shoulder and Hand questionnaire (DASH)
Disabilities as measured by the DASH scale; No Difficulty (1), Mild Difficulty (2), Moderate Difficulty (3), Severe Difficulty (4), Unable (5)
Time frame: All patients who underwent surgery between 2014 to 2023
Functional assessment: Goniometry
ROM of each joint of the hand with a goniometer
Time frame: All patients who underwent surgery between 2014 to 2023
Short-Form 36 (SF-36)
Scored review of health questionnaire SF36: minimum value = 0 ; maximum value = 100
Time frame: All patients who underwent surgery between 2014 to 2023
Ultrasound Assessment
Patients will undergo an ultrasound scan to assess the severity of their rheumatoid arthritis.
Time frame: All patients who underwent surgery between 2014 to 2023
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Apr 2024, 3 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Waldfriede Hospital